{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:25:18Z","timestamp":1778815518308,"version":"3.51.4"},"reference-count":83,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Science and High Education of the Russian Federation","award":["075-15-2021-1049"],"award-info":[{"award-number":["075-15-2021-1049"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Despite the wide variety of available cationic lipid platforms for the delivery of nucleic acids into cells, the optimization of their composition has not lost its relevance. The purpose of this work was to develop multi-component cationic lipid nanoparticles (LNPs) with or without a hydrophobic core from natural lipids in order to evaluate the efficiency of LNPs with the widely used cationic lipoid DOTAP (1,2-dioleoyloxy-3-[trimethylammonium]-propane) and the previously unstudied oleoylcholine (Ol-Ch), as well as the ability of LNPs containing GM3 gangliosides to transfect cells with mRNA and siRNA. LNPs containing cationic lipids, phospholipids and cholesterol, and surfactants were prepared according to a three-stage procedure. The average size of the resulting LNPs was 176 nm (PDI 0.18). LNPs with DOTAP mesylate were more effective than those with Ol-Ch. Core LNPs demonstrated low transfection activity compared with bilayer LNPs. The type of phospholipid in LNPs was significant for the transfection of MDA-MB-231 and SW 620 cancer cells but not HEK 293T cells. LNPs with GM3 gangliosides were the most efficient for the delivery of mRNA to MDA-MB-231 cells and siRNA to SW620 cells. Thus, we developed a new lipid platform for the efficient delivery of RNA of various sizes to mammalian cells.<\/jats:p>","DOI":"10.3390\/pharmaceutics15041289","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T04:53:59Z","timestamp":1681966439000},"page":"1289","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Multicomponent Lipid Nanoparticles for RNA Transfection"],"prefix":"10.3390","volume":"15","author":[{"given":"Nataliya","family":"Gretskaya","sequence":"first","affiliation":[{"name":"Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7467-4409","authenticated-orcid":false,"given":"Mikhail","family":"Akimov","sequence":"additional","affiliation":[{"name":"Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitry","family":"Andreev","sequence":"additional","affiliation":[{"name":"Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0132-0674","authenticated-orcid":false,"given":"Anton","family":"Zalygin","sequence":"additional","affiliation":[{"name":"Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia"},{"name":"Department of Translational Medicine, National Research Nuclear University, Moscow Engineering Physics Institute, Moscow 115409, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina","family":"Belitskaya","sequence":"additional","affiliation":[{"name":"Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia"},{"name":"Department of Translational Medicine, National Research Nuclear University, Moscow Engineering Physics Institute, Moscow 115409, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galina","family":"Zinchenko","sequence":"additional","affiliation":[{"name":"Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Fomina-Ageeva","sequence":"additional","affiliation":[{"name":"Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilya","family":"Mikhalyov","sequence":"additional","affiliation":[{"name":"Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0164-7423","authenticated-orcid":false,"given":"Elena","family":"Vodovozova","sequence":"additional","affiliation":[{"name":"Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8439-8607","authenticated-orcid":false,"given":"Vladimir","family":"Bezuglov","sequence":"additional","affiliation":[{"name":"Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Faneca, H. (2021). Non-Viral Gene Delivery Systems. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13040446"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2016.07.005","article-title":"Virus-inspired nucleic acid delivery system: Linking virus and viral mimicry","volume":"106","author":"Ni","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2022.01.008","article-title":"Non-viral vectors for RNA delivery","volume":"342","author":"Yan","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","article-title":"Chemistry of Lipid Nanoparticles for RNA Delivery","volume":"55","author":"Eygeris","year":"2022","journal-title":"Acc. Chem. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejpb.2013.07.002","article-title":"Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review","volume":"85","author":"Hadinoto","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-med-042420-112725","article-title":"mRNA Vaccines in the COVID-19 Pandemic and Beyond","volume":"73","author":"Hogan","year":"2022","journal-title":"Annu. Rev. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jconrel.2021.03.043","article-title":"The dawn of mRNA vaccines: The COVID-19 case","volume":"333","author":"Verbeke","year":"2021","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40290-021-00417-5","article-title":"Delivery Strategies for mRNA Vaccines","volume":"36","author":"Ramachandran","year":"2022","journal-title":"Pharm. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jconrel.2022.02.017","article-title":"Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery","volume":"344","author":"Maeki","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cis.2017.12.006","article-title":"A review on cationic lipids with different linkers for gene delivery","volume":"253","author":"Zhi","year":"2018","journal-title":"Adv. Colloid Interface Sci."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Haseda, Y., Munakata, L., Meng, J., Suzuki, R., and Aoshi, T. (2020). Microfluidic-prepared DOTAP nanoparticles induce strong T-cell responses in mice. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0227891"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Aldosari, B.N., Alfagih, I.M., and Almurshedi, A.S. (2021). Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13020206"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.ymthe.2022.02.016","article-title":"COVID-19 mRNA vaccines: Platforms and current developments","volume":"30","author":"Mahiny","year":"2022","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.copbio.2021.09.016","article-title":"Principles for designing an optimal mRNA lipid nanoparticle vaccine","volume":"73","author":"Kon","year":"2022","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1073\/pnas.84.21.7413","article-title":"Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure","volume":"84","author":"Felgner","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1021\/bc00029a002","article-title":"Gene Transfer with Synthetic Cationic Amphiphiles: Prospects for Gene Therapy","volume":"5","author":"Behr","year":"1994","journal-title":"Bioconjug. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v21.i4.10","article-title":"DOTAP (and other cationic lipids): Chemistry, biophysics, and transfection","volume":"21","author":"Simberg","year":"2004","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1021\/bc300381s","article-title":"The headgroup evolution of cationic lipids for gene delivery","volume":"24","author":"Zhi","year":"2013","journal-title":"Bioconj. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"9900","DOI":"10.1021\/jp403964k","article-title":"Effect of Hofmeister series anions on the thermotropic phase behavior of bioactive O-acylcholines","volume":"117","author":"Tarafdar","year":"2013","journal-title":"J. Phys. Chem. B"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Akimov, M.G., Kudryavtsev, D.S., Kryukova, E.V., Fomina-Ageeva, E.V., Zakharov, S.S., Gretskaya, N.M., Zinchenko, G.N., Serkov, I.V., Makhaeva, G.F., and Boltneva, N.P. (2020). Arachidonoylcholine and Other Unsaturated Long-Chain Acylcholines Are Endogenous Modulators of the Acetylcholine Signaling System. Biomolecules, 10.","DOI":"10.3390\/biom10020283"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1134\/S1607672920020027","article-title":"Neuroprotective and Antioxidant Activity of Arachidonoyl Choline, Its Bis-Quaternized Analogues and Other Acylcholines","volume":"491","author":"Akimov","year":"2020","journal-title":"Dokl. Biochem. Biophys."},{"key":"ref_22","first-page":"54106","article-title":"Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes","volume":"2016","author":"Bender","year":"2016","journal-title":"J. Vis. Exp. JoVE"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/978-1-4939-9092-4_26","article-title":"Lipopeptide Delivery of siRNA to the Central Nervous System","volume":"1943","author":"Zabel","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.omtm.2022.03.009","article-title":"A flexible, thermostable nanostructured lipid carrier platform for RNA vaccine delivery","volume":"25","author":"Gerhardt","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/bs.pmbts.2017.10.004","article-title":"Biology of GM3 Ganglioside","volume":"156","author":"Inokuchi","year":"2018","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1134\/S0006297909030018","article-title":"Ganglioside GM3 and its biological functions","volume":"74","author":"Prokazova","year":"2009","journal-title":"Biochem. Biokhimiia"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1021\/acsnano.5b06501","article-title":"Lipid-Mediated Targeting with Membrane-Wrapped Nanoparticles in the Presence of Corona Formation","volume":"10","author":"Xu","year":"2016","journal-title":"ACS Nano"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"E9041","DOI":"10.1073\/pnas.1804292115","article-title":"Membrane-wrapped nanoparticles probe divergent roles of GM3 and phosphatidylserine in lipid-mediated viral entry pathways","volume":"115","author":"Xu","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"18408","DOI":"10.1021\/acsnano.2c06516","article-title":"Ganglioside-Functionalized Nanoparticles for Chimeric Antigen Receptor T-Cell Activation at the Immunological Synapse","volume":"16","author":"Zang","year":"2022","journal-title":"ACS Nano"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0005-2760(80)90227-1","article-title":"A procedure for the quantitative isolation of brain gangliosides","volume":"617","author":"Svennerholm","year":"1980","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0009-3084(00)00121-3","article-title":"A simple approach to DOTAP and its analogs bearing different fatty acids","volume":"105","author":"Massing","year":"2000","journal-title":"Chem. Phys. Lipids"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1748-7188-6-26","article-title":"ViennaRNA Package 2.0","volume":"6","author":"Lorenz","year":"2011","journal-title":"Algorithms Mol. Biol. AMB"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41434-019-0095-2","article-title":"Inside out: Optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA","volume":"26","author":"Blakney","year":"2019","journal-title":"Gene Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"173346","DOI":"10.1016\/j.ejphar.2020.173346","article-title":"Novel bexarotene derivatives: Synthesis and cytotoxicity evaluation for glioma cells in 2D and 3D in vitro models","volume":"883","author":"Gretskaya","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Ye, J., Coulouris, G., Zaretskaya, I., Cutcutache, I., Rozen, S., and Madden, T.L. (2012). Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction. BMC Bioinform., 13.","DOI":"10.1186\/1471-2105-13-134"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s10895-012-1059-8","article-title":"SYBR Green I: Fluorescence properties and interaction with DNA","volume":"22","author":"Dragan","year":"2012","journal-title":"J. Fluoresc."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.bbamem.2015.06.020","article-title":"DOTAP\/DOPE ratio and cell type determine transfection efficiency with DOTAP-liposomes","volume":"1848","author":"Kim","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1208\/s12249-022-02294-w","article-title":"Optimization of DOTAP\/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery","volume":"23","author":"Sun","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.2147\/IJN.S363990","article-title":"Optimization of Lipid Nanoformulations for Effective mRNA Delivery","volume":"17","author":"Chen","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"114416","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Kulkarni","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0005-2736(00)00126-7","article-title":"Biophysical and lipofection studies of DOTAP analogs","volume":"1464","author":"Regelin","year":"2000","journal-title":"Biochim. Biophys. Acta BBA-Biomembr."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jconrel.2022.03.046","article-title":"The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs","volume":"345","author":"LoPresti","year":"2022","journal-title":"J. Control. Release"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1021\/jm0507227","article-title":"In vivo studies of dialkynoyl analogues of DOTAP demonstrate improved gene transfer efficiency of cationic liposomes in mouse lung","volume":"49","author":"Fletcher","year":"2006","journal-title":"J. Med. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Lechanteur, A., Sanna, V., Duchemin, A., Evrard, B., Mottet, D., and Piel, G. (2018). Cationic Liposomes Carrying siRNA: Impact of Lipid Composition on Physicochemical Properties, Cytotoxicity and Endosomal Escape. Nanomaterials, 8.","DOI":"10.3390\/nano8050270"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.3390\/molecules17033484","article-title":"Synthesis and preliminary investigations of the siRNA delivery potential of novel, single-chain rigid cationic carotenoid lipids","volume":"17","author":"Pungente","year":"2012","journal-title":"Molecules"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.numecd.2020.01.004","article-title":"Serum metabolites associate with lipid phenotypes among Bogalusa Heart Study participants","volume":"30","author":"Gu","year":"2020","journal-title":"Nutr. Metab. Cardiovasc. Dis. NMCD"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"14373","DOI":"10.1073\/pnas.0603085103","article-title":"An intracellular lamellar\u2013nonlamellar phase transition rationalizes the superior performance of some cationic lipid transfection agents","volume":"103","author":"Koynova","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.biochi.2019.02.012","article-title":"Strategies in the design of endosomolytic agents for facilitating endosomal escape in nanoparticles","volume":"160","author":"Ahmad","year":"2019","journal-title":"Biochimie"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.addr.2016.01.022","article-title":"The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery","volume":"99","author":"Cheng","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1248\/bpb.25.891","article-title":"Comparison of the efficiency and safety of non-viral vector-mediated gene transfer into a wide range of human cells","volume":"25","author":"Uchida","year":"2002","journal-title":"Biol. Pharm. Bull."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0006-3495(96)79309-8","article-title":"The role of helper lipids in cationic liposome-mediated gene transfer","volume":"71","author":"Hui","year":"1996","journal-title":"Biophys. J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1039\/D1BM01454D","article-title":"Optimization of phospholipid chemistry for improved lipid nanoparticle (LNP) delivery of messenger RNA (mRNA)","volume":"10","author":"Farbiak","year":"2022","journal-title":"Biomater. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jconrel.2005.02.001","article-title":"Preparation of plasmid DNA-containing liposomes using a high-pressure homogenization-extrusion technique","volume":"104","author":"Pupo","year":"2005","journal-title":"J. Control. Release"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.bbamem.2008.04.009","article-title":"Cholesterol domains in cationic lipid\/DNA complexes improve transfection","volume":"1778","author":"Xu","year":"2008","journal-title":"Biochim. Biophys. Acta BBA-Biomembr."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.apsb.2021.08.011","article-title":"Inhibiting collagen I production and tumor cell colonization in the lung via miR-29a-3p loading of exosome-\/liposome-based nanovesicles","volume":"12","author":"Yan","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1049\/nbt2.12028","article-title":"Liposome nano-formulation with cationic polar lipid DOTAP and cholesterol as a suitable pH-responsive carrier for molecular therapeutic drug (all-trans retinoic acid) delivery to lung cancer cells","volume":"15","author":"Grace","year":"2021","journal-title":"IET Nanobiotechnol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1021\/mp200426h","article-title":"SPANosomes as delivery vehicles for small interfering RNA (siRNA)","volume":"9","author":"Zhou","year":"2012","journal-title":"Mol. Pharm."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.colsurfb.2006.03.014","article-title":"Cationic liposomes modified with non-ionic surfactants as effective non-viral carrier for gene transfer","volume":"49","author":"Huang","year":"2006","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.ymthe.2018.07.010","article-title":"A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against Zika","volume":"26","author":"Erasmus","year":"2018","journal-title":"Mol. Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ijpharm.2018.07.035","article-title":"Polysorbate 20 non-ionic surfactant enhances retinal gene delivery efficiency of cationic niosomes after intravitreal and subretinal administration","volume":"550","author":"Gallego","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12032-022-01836-3","article-title":"Niosomes: A novel targeted drug delivery system for cancer","volume":"39","author":"Moghtaderi","year":"2022","journal-title":"Med. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.2147\/DDDT.S178532","article-title":"Gene transfer to rat cerebral cortex mediated by polysorbate 80 and poloxamer 188 nonionic surfactant vesicles","volume":"12","author":"Attia","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.colsurfb.2014.04.016","article-title":"Cationic vesicles based on non-ionic surfactant and synthetic aminolipids mediate delivery of antisense oligonucleotides into mammalian cells","volume":"119","author":"Grijalvo","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"17448069221150138","DOI":"10.1177\/17448069221150138","article-title":"Polysorbate 80 blocked a peripheral sodium channel, Nav1.7, and reduced neuronal excitability","volume":"19","author":"Kim","year":"2022","journal-title":"Mol. Pain"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0005-2736(97)00126-0","article-title":"Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells","volume":"1329","author":"Filion","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/sj.gt.3300863","article-title":"Lipoplex size is a major determinant of in vitro lipofection efficiency","volume":"6","author":"Ross","year":"1999","journal-title":"Gene Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1042\/bj20031253","article-title":"Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis","volume":"377","author":"Rejman","year":"2004","journal-title":"Biochem. J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jconrel.2007.08.022","article-title":"Lipoplex morphologies and their influences on transfection efficiency in gene delivery","volume":"123","author":"Ma","year":"2007","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1517\/17425240902828312","article-title":"Atomic force microscopy: A tool to study the structure, dynamics and stability of liposomal drug delivery systems","volume":"6","author":"Spyratou","year":"2009","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.talanta.2013.03.080","article-title":"A label-free signal amplification assay for DNA detection based on exonuclease III and nucleic acid dye SYBR Green, I","volume":"114","author":"Zheng","year":"2013","journal-title":"Talanta"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"113768","DOI":"10.1016\/j.ab.2020.113768","article-title":"Reverse transcriptase kinetics for one-step RT-PCR","volume":"601","author":"Rejali","year":"2020","journal-title":"Anal. Biochem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid Nanoparticles\u2500From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1023\/A:1016278302046","article-title":"Structures of nanoparticles prepared from oil-in-water emulsions","volume":"12","author":"Kaplun","year":"1995","journal-title":"Pharm. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.xphs.2016.11.019","article-title":"Real-Time Visualization of the Precipitation and Phase Behavior of Octaethylporphyrin in Lipid Microparticles","volume":"106","author":"Parra","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1016\/j.ymthe.2017.08.006","article-title":"Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques","volume":"25","author":"Liang","year":"2017","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jconrel.2021.01.029","article-title":"Liposome induction of CD8+ T cell responses depends on CD169+ macrophages and Batf3-dependent dendritic cells and is enhanced by GM3 inclusion","volume":"331","author":"Grabowska","year":"2021","journal-title":"J. Control. Release"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"6414","DOI":"10.1021\/bi0101998","article-title":"GM3 ganglioside inhibits CD9-facilitated haptotactic cell motility: Coexpression of GM3 and CD9 is essential in the downregulation of tumor cell motility and malignancy","volume":"40","author":"Ono","year":"2001","journal-title":"Biochemistry"},{"key":"ref_78","first-page":"3994","article-title":"Gangliosides and CD82 inhibit the motility of colon cancer by downregulating the phosphorylation of EGFR at different tyrosine sites and signaling pathways","volume":"22","author":"Huang","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"ref_79","first-page":"105","article-title":"siRNA therapeutics for breast cancer: Recent efforts in targeting metastasis, drug resistance, and immune evasion","volume":"214","author":"Ngamcherdtrakul","year":"2019","journal-title":"Transl. Res. J. Lab. Clin. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/21691401.2017.1307210","article-title":"Advances in siRNA delivery in cancer therapy","volume":"46","author":"Singh","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/aps.2017.157","article-title":"The LPI\/GPR55 axis enhances human breast cancer cell migration via HBXIP and p-MLC signaling","volume":"39","author":"Zhou","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.tips.2018.02.011","article-title":"Lysophosphatidylinositols, from Cell Membrane Constituents to GPR55 Ligands","volume":"39","author":"Alhouayek","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1021\/la3050576","article-title":"Heterogeneous cationic liposomes modified with 3\u03b2-{N-[(N\u2032,N\u2032-dimethylamino)ethyl]carbamoyl}cholesterol can induce partial conformational changes in messenger RNA and regulate translation in an Escherichia coli cell-free translation system","volume":"29","author":"Suga","year":"2013","journal-title":"Langmuir ACS J. Surf. Colloids"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/15\/4\/1289\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:19:33Z","timestamp":1760123973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/15\/4\/1289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,20]]},"references-count":83,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["pharmaceutics15041289"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics15041289","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,20]]}}}